Real-World Inpatient Use of Medications Repurposed for Coronavirus Disease 2019 in United States Hospitals, March–May 2020

We report off-label use patterns for medications repurposed for coronavirus disease 2019 (COVID-19) at 318 US hospitals. Inpatient hydroxychloroquine use declined by 80%, whereas corticosteroids and tocilizumab were initiated 2 days earlier in May versus March 2020. Two thirds of ventilated COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadri, Sameer S, Demirkale, Cumhur Y, Sun, Junfeng, Busch, Lindsay M, Strich, Jeffrey R, Rosenthal, Ning, Warner, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798707/
https://www.ncbi.nlm.nih.gov/pubmed/33556157
http://dx.doi.org/10.1093/ofid/ofaa616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798707/
https://www.ncbi.nlm.nih.gov/pubmed/33556157
http://dx.doi.org/10.1093/ofid/ofaa616

Ejemplares similares